Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. (Q48708325)

14 February 2018

title

Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease. (English)

1 reference

14 February 2018

main subject

Alzheimer's disease

0 references

author

Winnie Deuther-Conrad

1 reference

ORCID Public Data File 2021

author name string

Wong A

1

1 reference

14 February 2018

Lüth HJ

2

1 reference

14 February 2018

Deuther-Conrad W

3

1 reference

14 February 2018

Dukic-Stefanovic S

4

1 reference

14 February 2018

Gasic-Milenkovic J

5

1 reference

14 February 2018

Arendt T

6

1 reference

14 February 2018

Münch G

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 November 2001

1 reference

14 February 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

14 February 2018

volume

920

1 reference

14 February 2018

page(s)

32-40

1 reference

14 February 2018

issue

1-2

1 reference

14 February 2018

Inflammation and Alzheimer disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Endogenous nitric oxide synthesis: biological functions and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Glycation and microglial reaction in lesions of Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Activation of glial cells by human coronavirus OC43 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Aging, metabolism, and Alzheimer disease: review and hypotheses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Antioxidants, oxidative stress, and degenerative neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Beta 2-microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Diagnosis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Nitric oxide: from discovery to the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Peroxynitrite and nitric oxide donors induce neuronal apoptosis by eliciting autocrine excitotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Differential expression of advanced glycosylation end-products in neurons of different species.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Activation of microglial cells by beta-amyloid protein and interferon-gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

The role of oxidative stress and NF-kappaB activation in late diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Widespread peroxynitrite-mediated damage in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Redox signaling: nitrosylation and related target interactions of nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Advanced glycation end products contribute to amyloidosis in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Microglia cells are the driving force in fibrillar plaque formation, whereas astrocytes are a leading factor in plague degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902872-4

10.1016/S0006-8993(01)02872-4

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

11716809

1 reference

14 February 2018